Search Within

Han Xiao

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Population Sciences Research Program (12)
  4. Solid Tumor Oncology Division (12)
  5. Epidemiology and Biostatistics (10)
  6. Survivorship Research (8)

More Groups

People
  1. Jun Mao (6)
  2. Gary Deng (4)
  3. Katherine Panageas (4)
  4. Kevin Liou (4)
  5. Qing Li (4)
  6. Raymond Baser (4)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Annals of Oncology (1)
  3. BMJ Open (1)
  4. Cancer (1)
  5. European Urology Oncology (1)
  6. JAMA Network Open (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Medical Association (1)
  3. BMJ Publishing Group Ltd. (1)
  4. Elsevier BV (1)
  5. Oxford University Press (1)
  6. Springer Verlag (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI)
    Meeting Abstract

    Lang, J. M.; Tagawa, S. T.; Slovin, S.; Sperger, J. M.; Schehr, J. L.; Stahlfeld, C.; Hintz, A. M.; Emamekhoo, H.; Rathkopf, D.; Abida, W.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Acupuncture vs massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Journal Article

    Epstein, A. S.; Liou, K. T.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Mo, Z. L.; Walker, D.; MacLeod, J.; Li, Q.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Deng, G.; Mo, Z.; Walker, D.; MacLeod, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Acupuncture versus massage for pain in patients living with advanced cancer: A protocol for the IMPACT randomised clinical trial
    Journal Article

    Romero, S. A. D.; Emard, N.; Baser, R. E.; Panageas, K.; MacLeod, J.; Walker, D.; Barton-Burke, M.; Liou, K.; Deng, G.; Farrar, J.; more...
    BMJ Open (2022)

    Fulltext@MSK | Save
  • Understanding interest, barriers, and preferences related to yoga practice among cancer survivors
    Journal Article

    Desai, K.; Bao, T.; Li, Q. S.; Raghunathan, N. J.; Trevino, K.; Green, A.; Xiao, H.; Mao, J. J.
    Supportive Care in Cancer (2021)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Implementation of Symptom Care Clinic (SCC) for acute symptoms management at outpatient oncology ambulatory centers
    Meeting Abstract

    Xiao, H.; Fahy, R.; Salvaggio, R.; OSullivan, M.; Sokoli, D.; Murray, C.; Majeed, J.; Mao, J. J.; Groeger, J. S.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Panageas, K.; Baser, R. E.; Romero, S. A. D.; Li, Q. S.; Xiao, H.; Bao, T.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save